Results 161 to 170 of about 7,247,788 (281)

Diabetes mellitus, ABO Blood groups, and biochemical correlates in pancreatic cancer- A retrospective study from Jeddah. [PDF]

open access: yesJ Family Med Prim Care
Aga SS   +7 more
europepmc   +1 more source

Pretransfusion testing interference profile of IMC‐002: A novel anti‐CD47 monoclonal antibody engineered for minimized red cell binding

open access: yesTransfusion, EarlyView.
Abstract Background CD47‐targeted agents can interfere with pretransfusion testing due to CD47 expression on red blood cells (RBCs). IMC‐002 is a novel anti‐CD47 human IgG4 monoclonal antibody engineered to minimize RBC binding; however, its interference profile during pretransfusion testing remains poorly characterized.
Tae‐Shin Kim   +5 more
wiley   +1 more source

Mapping obstetric biobanks: A scoping review highlighting gaps in the study of alloimmunized pregnancies

open access: yesTransfusion, EarlyView.
Abstract Background Maternal red cell alloimmunization can cause hemolytic disease of the fetus and newborn (HDFN), yet prediction of disease severity remains limited. Biobanks that link pregnancy biospecimens with clinical and laboratory data could accelerate translational research; however, the landscape of relevant obstetric biobanks has not been ...
Orlin Chowdhury   +10 more
wiley   +1 more source

Impact of ABO blood groups on residual pulmonary vascular obstruction in patients with unprovoked pulmonary embolism. [PDF]

open access: yesBlood Vessel Thromb Hemost
Samaria F   +13 more
europepmc   +1 more source

Pediatric ABO blood groups and disease distribution: a retrospective analysis. [PDF]

open access: yesTransl Pediatr
Yang W   +6 more
europepmc   +1 more source

Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization

open access: yes, 2018
Qing Li,1,* Tao Wu,1,* Xiao-An Ma,2,* Li Jing,1 Li-Li Han,3 Hui Guo1 1Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 2Department of General ...
Jing L, Han L, Guo H, Ma X, Li Q, Wu T
core  

Implementation of soluble CD38 in blood crossmatching for patients on anti‐CD38 therapy: A single‐center experience

open access: yesTransfusion, EarlyView.
Abstract Background Human monoclonal (MoAb) anti‐CD38 antibodies, such as daratumumab, are used to treat diseases such as multiple myeloma. Because red blood cells (RBCs) express CD38, these MoAbs interfere with antibody screening and crossmatching in blood banks.
Ayda Javanbakht   +3 more
wiley   +1 more source

ABO Blood Groups in Systemic Sclerosis: Distribution and Association with This Disease's Characteristics. [PDF]

open access: yesJ Clin Med, 2022
Collet A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy